文献速递冠心病血脂与心血管预防

基于声学的稳定冠心病排除策略:FILTER-SCAD 试验

Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
PubMed 文献 · Eur Heart J · 2025-01-01

FILTER-SCAD 试验在丹麦和瑞典六个门诊将疑似新发慢性冠脉综合征患者随机分组,比较标准诊断检查(SDE)联合 PTP 与额外提供 CAD-score 及流程图对限制检查的影响。结果显示整体诊断检查数量无差异,但在 PTP≤5% 亚组中延迟检查比例从 28% 升至 52%,安全性非劣效。

要点

  • 在 PTP≤5% 的低风险患者中,提供 CAD-score 使延迟检查比例从 28% 提高至 52%。
  • 整体人群诊断检查数量无显著减少,CAD-score 策略未优于单用 PTP。
  • MACE 发生率为 2.4/100 人年,CAD-score 策略安全性非劣效(绝对风险差 0.49%,95%CI -1.96-0.97)。

核心结论

  • 在标准诊断检查中额外提供 CAD-score 未能减少整体诊断检查数量,但可能有助于低 CCS 概率患者的检查决策。

研究设计与样本

  • 多中心随机对照试验,纳入 2008 例疑似新发慢性冠脉综合征患者,随机接受标准诊断检查(SDE)加 PTP 或 SDE 加 CAD-score,随访 1 年。

主要发现

  • CAD-score 组中 94.5% 成功测量,13.5% 患者 PTP≤5%,39.5% 患者 CAD-score≤20%。
  • 心绞痛相关健康状况和生活质量无差异。

关键数值与推荐

  • PTP≤5% 定义为低风险亚组,CAD-score≤20% 为另一低风险阈值。

临床怎么用

  • 对于 PTP≤5% 的疑似慢性冠脉综合征患者,可考虑结合 CAD-score 以支持延迟诊断检查的决策。
  • 在整体疑似 CCS 人群中,提供 CAD-score 并未显著改变诊断检查行为。

局限性

  • 研究仅纳入丹麦和瑞典六个门诊,外推性受限。
  • 整体诊断检查数量未减少,提示存在改变诊断路径的阻力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Overtesting of low-risk patients with suspect chronic coronary syndrome (CCS) is widespread. The acoustic-based coronary artery disease (CAD)-score has superior rule-out capabilities when added to pre-test probability (PTP). FILTER-SCAD tested whether providing a CAD-score and PTP to cardiologists was superior to PTP alone in limiting testing. METHODS: At six Danish and Swedish outpatient clinics, patients with suspected new-onset CCS were randomized to either standard diagnostic examination (SDE) with PTP, or SDE plus CAD-score, and cardiologists provided with corresponding recommended diagnostic flowcharts. The primary endpoint was cumulative number of diagnostic tests at one year and key safety endpoint major adverse cardiac events (MACE). RESULTS: In total, 2008 patients (46% male, median age 63 years) were randomized from October 2019 to September 2022. When randomized to CAD-score (n = 1002), it was successfully measured in 94.5%. Overall, 13.5% had PTP ≤ 5%, and 39.5% had CAD-score ≤ 20. Testing was deferred in 22% with no differences in diagnostic tests between groups (P for superiority = .56). In the PTP ≤ 5% subgroup, the proportion with deferred testing increased from 28% to 52% (P < .001). Overall MACE was 2.4 per 100 person-years. Non-inferiority regarding safety was established, absolute risk difference 0.49% (95% confidence interval -1.96-0.97) (P for non-inferiority = .003). No differences were seen in angina-related health status or quality of life. CONCLUSIONS: The implementation strategy of providing cardiologists with a CAD-score alongside SDE did not reduce testing overall but indicated a possible role in patients with low CCS likelihood. Further strategies are warranted to address resistance to modifying diagnostic pathways in this patient population.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Bjerking LH, Skak-Hansen KW, Heitmann M, et al. Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial. Eur Heart J. 2025. PMID: 39217444. doi:10.1093/eurheartj/ehae570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。